Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on February 13, 2003

Stroke. 2003
Published online before print February 13, 2003, doi: 10.1161/01.STR.0000057814.70180.17
A more recent version of this article appeared on March 1, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/3/745    most recent
01.STR.0000057814.70180.17v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schäbitz, W.-R.
Right arrow Articles by Schwab, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schäbitz, W.-R.
Right arrow Articles by Schwab, S.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Transient Ischemic Attack
Related Collections
Right arrow Animal models of human disease
Right arrow Acute Cerebral Infarction
Right arrow Pathology of Stroke
Right arrow Neuroprotectors
Right arrow Other Stroke Treatment - Medical

Submitted on September 12, 2002
Accepted on September 27, 2002

Neuroprotective Effect of Granulocyte Colony-Stimulating Factor After Focal Cerebral Ischemia

W.-R. Schäbitz MD; R. Kollmar MD; M. Schwaninger MD; E. Juettler MD; J. Bardutzky MD; M. N. Schölzke MD; C. Sommer MD*; and S. Schwab MD

From the Department of Neurology and the Department of Neuropathology (C.S.), University of Heidelberg, Heidelberg, Germany.

* To whom correspondence should be addressed. E-mail: clemens.sommer{at}medizin.uni-ulm.de.

Background and Purpose--The potential neuroprotective effect of the granulocyte colony-stimulating factor (G-CSF) after glutamate-induced excitotoxicity in cell culture and after focal cerebral ischemia in rats was studied. We hypothesized the existence of the G-CSF receptor (G-CSFR) as a main G-CSF effector on neurons, and immunohistochemistry, immunoblotting, and polymerase chain reaction were performed. The G-CSFR-mediated action was studied by activation of signal transducer(s) and activator(s) of transcription-3 (STAT3) in the periphery of the infarction.

Methods--Neuroprotection of various G-CSF concentrations on glutamate-induced excitotoxicity was studied in cell culture. In vivo, ischemia was induced by use of a suture occlusion model of the middle cerebral artery (90-minute occlusion) in the rat. Thirty minutes after the induction of ischemia, the animals (n=12 per group) received G-CSF at 60 µg/kg body wt IV for 90 minutes or vehicle (saline). Infarct volume was calculated on the basis of 2,3,5-triphenyltetrazolium chloride staining 24 hours after ischemia. Expression of the G-CSFR was studied by immunohistochemistry and verified by reverse transcription-polymerase chain reaction and immunoblotting. Expression of STAT3 was determined by immunohistochemistry.

Results--In cell culture, G-CSF exhibited a significant neuroprotective effect after glutamate-induced excitotoxicity (P<0.05). A G-CSF concentration of 10 ng/mL was maximally effective, resulting in a nearly complete protection. In vivo, G-CSF reduced infarct volume to 47% (132.0±112.7 mm3 versus 278.9±91.6 mm3 [P<0.05] in the control group). Immunohistochemistry, Western blotting, and reverse transcription-polymerase chain reaction revealed the existence of G-CSFRs in neurons and glial cells. Animals treated with G-CSF significantly upregulated STAT3 in the periphery of the infarction compared with control animals (P<0.05).

Conclusions--G-CSF achieved a significant neuroprotective effect in cell culture and after intravenous administration after stroke. Increased STAT3 expression in the penumbra of G-CSF-treated rats suggests mediation by G-CSFR.


Key words: colony-stimulating factor, granulocyte • excitotoxicity • growth factors • ischemia • neuroprotection




This article has been cited by other articles:


Home page
J. Neurosci.Home page
K. Diederich, S. Sevimli, H. Dorr, E. Kosters, M. Hoppen, L. Lewejohann, R. Klocke, J. Minnerup, S. Knecht, S. Nikol, et al.
The Role of Granulocyte-Colony Stimulating Factor (G-CSF) in the Healthy Brain: A Characterization of G-CSF-Deficient Mice
J. Neurosci., September 16, 2009; 29(37): 11572 - 11581.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. T. Bratane, J. Bouley, A. Schneider, B. Bastan, N. Henninger, and M. Fisher
Granulocyte-Colony Stimulating Factor Delays PWI/DWI Mismatch Evolution and Reduces Final Infarct Volume in Permanent-Suture and Embolic Focal Cerebral Ischemia Models in the Rat
Stroke, September 1, 2009; 40(9): 3102 - 3106.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. Hochsmann, R. Huber, P. Schauwecker, H. Schrezenmeier, M. Wiesneth, and A. Storch
HEMISPHERIC STROKE DOES NOT MOBILIZE CD34+ HEMATOPOIETIC STEM CELLS INTO THE PERIPHERAL BLOOD
Neurology, April 7, 2009; 72(14): 1277 - 1278.
[Full Text] [PDF]


Home page
StrokeHome page
M. Philip, M. Benatar, M. Fisher, and S. I. Savitz
Methodological Quality of Animal Studies of Neuroprotective Agents Currently in Phase II/III Acute Ischemic Stroke Trials
Stroke, February 1, 2009; 40(2): 577 - 581.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. Oishi, A. Otani, M. Sasahara, H. Kojima, H. Nakamura, Y. Yodoi, and N. Yoshimura
Granulocyte Colony-Stimulating Factor Protects Retinal Photoreceptor Cells against Light-Induced Damage
Invest. Ophthalmol. Vis. Sci., December 1, 2008; 49(12): 5629 - 5635.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. Pitzer, C. Kruger, C. Plaas, F. Kirsch, T. Dittgen, R. Muller, R. Laage, S. Kastner, S. Suess, R. Spoelgen, et al.
Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis
Brain, December 1, 2008; 131(12): 3335 - 3347.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Minnerup, J. Heidrich, J. Wellmann, A. Rogalewski, A. Schneider, and W.-R. Schabitz
Meta-Analysis of the Efficacy of Granulocyte-Colony Stimulating Factor in Animal Models of Focal Cerebral Ischemia
Stroke, June 1, 2008; 39(6): 1855 - 1861.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
T. Matsumoto, M. Moriya, H. Kiyohara, Y. Tabuchi, and H. Yamada
Hochuekkito, a Kampo (Traditional Japanese Herbal) Medicine, and its Polysaccharide Portion Stimulate G-CSF Secretion from Intestinal Epithelial Cells
Evid. Based Complement. Altern. Med., February 27, 2008; (2008) nen007v1.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L.-R. Zhao, H. H. Berra, W.-M. Duan, S. Singhal, J. Mehta, A. V. Apkarian, and J. A. Kessler
Beneficial Effects of Hematopoietic Growth Factor Therapy in Chronic Ischemic Stroke in Rats
Stroke, October 1, 2007; 38(10): 2804 - 2811.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
K.-J. Tsai, Y.-C. Tsai, and C.-K. J. Shen
G-CSF rescues the memory impairment of animal models of Alzheimer's disease
J. Exp. Med., June 11, 2007; 204(6): 1273 - 1280.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
N. Sprigg, P. M. Bath, L. Zhao, M. R. Willmot, L. J. Gray, M. F. Walker, M. S. Dennis, and N. Russell
Granulocyte-Colony-Stimulating Factor Mobilizes Bone Marrow Stem Cells in Patients With Subacute Ischemic Stroke: The Stem Cell Trial of Recovery EnhanceMent After Stroke (STEMS) Pilot Randomized, Controlled Trial (ISRCTN 16784092)
Stroke, December 1, 2006; 37(12): 2979 - 2983.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
I. Solaroglu, J. Cahill, V. Jadhav, and J. H. Zhang
A Novel Neuroprotectant Granulocyte-Colony Stimulating Factor
Stroke, April 1, 2006; 37(4): 1123 - 1128.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Fisher, A. Davalos, A. Rogalewski, A. Schneider, E. B. Ringelstein, and W.-R. Schabitz
Toward a Multimodal Neuroprotective Treatment of Stroke
Stroke, April 1, 2006; 37(4): 1129 - 1136.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
W.-C. Shyu, S.-Z. Lin, C.-C. Lee, D. D. Liu, and H. Li
Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial
Can. Med. Assoc. J., March 28, 2006; 174(7): 927 - 933.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
C. V. Borlongan and D. C. Hess
New hope for stroke patients: mobilization of endogenous stem cells
Can. Med. Assoc. J., March 28, 2006; 174(7): 954 - 955.
[Full Text] [PDF]


Home page
CirculationHome page
H. Kawada, S. Takizawa, T. Takanashi, Y. Morita, J. Fujita, K. Fukuda, S. Takagi, H. Okano, K. Ando, and T. Hotta
Administration of Hematopoietic Cytokines in the Subacute Phase After Cerebral Infarction Is Effective for Functional Recovery Facilitating Proliferation of Intrinsic Neural Stem/Progenitor Cells and Transition of Bone Marrow-Derived Neuronal Cells
Circulation, February 7, 2006; 113(5): 701 - 710.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
U. Bottoni, P. Bonaccorsi, V. Devirgiliis, V. Panasiti, R. G. Borroni, G. Trasimeni, R. Clerico, and S. Calvieri
Complete Remission of Brain Metastases in Three Patients with Stage IV Melanoma Treated with BOLD and G-CSF
Jpn. J. Clin. Oncol., September 1, 2005; 35(9): 507 - 513.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Ehrenreich, M. Hasselblatt, F. Knerlich, N. von Ahsen, S. Jacob, S. Sperling, H. Woldt, K. Vehmeyer, K.-A. Nave, and A.-L. Siren
A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain
PNAS, January 18, 2005; 102(3): 862 - 867.
[Abstract] [Full Text] [PDF]